204 related articles for article (PubMed ID: 32825943)
21. Diagnostic dilemmas in enlarged and diffusely hemorrhagic adrenal glands.
Diolombi ML; Khani F; Epstein JI
Hum Pathol; 2016 Jul; 53():63-72. PubMed ID: 27001431
[TBL] [Abstract][Full Text] [Related]
22. Challenges in surgical pathology of adrenocortical tumours.
Erickson LA
Histopathology; 2018 Jan; 72(1):82-96. PubMed ID: 29239032
[TBL] [Abstract][Full Text] [Related]
23. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
[TBL] [Abstract][Full Text] [Related]
24. A rare case of oncocytic adrenocortical carcinoma clinically presented as an incidentaloma.
Harada K; Yasuda M; Nakano Y; Yoshida K; Umeda Y; Yagi T; Yamazaki Y; Sasano H; Otsuka F
Endocr J; 2020 Aug; 67(8):883-888. PubMed ID: 32249250
[TBL] [Abstract][Full Text] [Related]
25. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
26. Concurrent pheochromocytoma and cortical carcinoma of the adrenal gland.
Fassina A; Cappellesso R; Schiavi F; Fassan M
J Surg Oncol; 2011 Jan; 103(1):103-4. PubMed ID: 21031430
[No Abstract] [Full Text] [Related]
27. [Morphometric characteristics of the cells in non-tumoral processes and tumors of the adrenal glands].
Smol'ianinova NV; Shapiro NA; Isakov VL
Lab Delo; 1989; (11):51-4. PubMed ID: 2481104
[TBL] [Abstract][Full Text] [Related]
28. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Fassnacht M; Assie G; Baudin E; Eisenhofer G; de la Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;
Ann Oncol; 2020 Nov; 31(11):1476-1490. PubMed ID: 32861807
[No Abstract] [Full Text] [Related]
29. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
Wang C; Sun Y; Wu H; Zhao D; Chen J
Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
[TBL] [Abstract][Full Text] [Related]
30. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
Browning L; Bailey D; Parker A
J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
[TBL] [Abstract][Full Text] [Related]
31. [Pathologic anatomy of adrenal tumors].
Richter HJ
Radiologe; 1980 Apr; 20(4):149-57. PubMed ID: 7413971
[TBL] [Abstract][Full Text] [Related]
32. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
Sasano H; Suzuki T; Moriya T
Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature.
Wanis KN; Kanthan R
World J Surg Oncol; 2015 Mar; 13():117. PubMed ID: 25889798
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
Giordano TJ
Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
[TBL] [Abstract][Full Text] [Related]
36. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
Menon V; Krishnamurthy SV
Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
[TBL] [Abstract][Full Text] [Related]
37. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
[TBL] [Abstract][Full Text] [Related]
38. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
[TBL] [Abstract][Full Text] [Related]
39. [Value of sonography, computed tomography and angiography in adrenal diagnosis].
Georgi M; Hofbauer J; Weiss H; Keller W; Wunschik F; von Mittelstaedt G; Linder M
Rofo; 1984 Apr; 140(4):373-9. PubMed ID: 6425158
[TBL] [Abstract][Full Text] [Related]
40. Computed tomography (CT) scan identified necrosis, but is it a reliable single parameter for discerning between malignant and benign adrenocortical tumors?
Garay-Lechuga D; Pérez-Soto RH; Hernández-Acevedo JD; Butrón-Hernández D; Sierra-Salazar M; Pantoja-Millán JP; Herrera MF; Velázquez-Fernández D
Surgery; 2022 Jan; 171(1):104-110. PubMed ID: 34183180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
